| Financial Year |
March 31 2023 |
| Monetary Funds |
96,847,409.95 |
| Held-for-trading Financial Assets |
317,795,616.52 |
| Notes Receivable |
770,000.00 |
| Accounts Receivable |
76,896,923.33 |
| Advances to Suppliers |
25,556,115.84 |
| Other Receivables |
2,799,058.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
138,843,313.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,397,424.94 |
| Total Current Assets |
756,131,103.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,000,893.39 |
| Investment Properties |
283,120.12 |
| Fixed Assetes |
547,477,028.33 |
| Under-construction Projects |
61,002,088.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,771,709.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
38,204.54 |
| Deferred Income Tax Assets |
42,133,614.20 |
| Other Non-Current Assets |
21,507,718.05 |
| Sub-Total of Non-Current Assets |
776,357,394.41 |
| Total Assets |
1,532,488,497.61 |
| Short-Term Loans |
295,320,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,725,260.49 |
| Accounts Payable |
54,412,788.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,555,814.19 |
| Taxes Payable |
4,662,450.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,310,037.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,028,875.00 |
| Other Current Liabilities |
1,059,478.90 |
| Sub-Total of Current Liabilities |
484,348,347.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,560,717.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,965,335.86 |
| Total Liabilities |
527,313,683.25 |
| Paid-In Capital(Or Share Stock) |
60,000,000.00 |
| Capital Surplus |
537,189,324.19 |
| Surplus Reserve |
30,000,000.00 |
| LESS:Treasury Stock |
25,418,400.00 |
| Undistributed Profits |
402,513,343.54 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,005,174,814.36 |
| Owner's Equity（Stockholder's Equity） |
1,005,174,814.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,532,488,497.61 |
